Jesse Roth

Dr. Jesse Roth, a distinguished American endocrinologist and physician whose groundbreaking research profoundly advanced the understanding and treatment of diabetes and other metabolic disorders, passed away on March 11, 2026, at the age of 91. His remarkable career spanned over five decades, marked by pioneering scientific discoveries, dedicated public service, and a commitment to mentorship that shaped generations of medical researchers.

Born in New York City on August 5, 1934, Jesse Roth embarked on his academic journey at Columbia University, earning his Bachelor of Arts degree in 1955. He then pursued his medical education at the Albert Einstein College of Medicine, where he received his Doctor of Medicine degree in 1959. This foundational training set the stage for a lifetime dedicated to unraveling the complexities of human physiology and disease.

Dr. Roth's early career was significantly influenced by his fellowship work with Nobel laureates Solomon Berson and Rosalyn Yalow at the Bronx Veterans Administration Medical Center in 1963. It was during this period that he began his seminal research on insulin action, a field he would revolutionize. His collaboration with Berson and Yalow led to the development of new tests for diagnosing growth hormone secretion disorders, which remain gold standards in the field.

A pivotal achievement in Dr. Roth's career was his pioneering work on the concept of cell surface receptors. His laboratory at the National Institutes of Health (NIH), where he served from 1963 to 1991, meticulously elucidated the structure of the insulin receptor and the intricate intracellular mechanisms of insulin action. This research provided critical insights into how hormones communicate with cells and how these interactions are altered in disease states, laying the groundwork for much of modern endocrinology.

Beyond his scientific endeavors, Dr. Roth dedicated a significant portion of his career to public service. From 1985 to 1991, he held the esteemed position of Assistant Surgeon General of the United States, contributing his expertise to national health initiatives. His leadership extended to various roles at the NIH, including Chief of the Diabetes Branch and Scientific Director of the National Institute of Diabetes and Digestive and Kidney Diseases.

His exceptional contributions to medicine were widely recognized through numerous prestigious awards and honors. Dr. Roth was a recipient of the 1980 Gairdner Foundation International Award, a testament to his global impact on medical science. In 1982, he was honored with the American Diabetes Association's Banting Medal for Scientific Achievement, the highest scientific award in diabetes research. That same year, he was elected to the American Academy of Arts and Sciences, acknowledging his intellectual leadership.

After his extensive tenure at the NIH, Dr. Roth accepted a professorship of internal medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland, in 1990, where he also directed the Division of Geriatrics and Gerontology. In 2000, he joined Northwell Health, where he led the Laboratory for Diabetes and Diabetes-Related Disorders at The Feinstein Institute for Medical Research, continuing his vital research and mentorship. He also held professorships at Hofstra North Shore-LIJ School of Medicine and Albert Einstein College of Medicine.

Dr. Roth's legacy is not only in his scientific discoveries but also in his profound influence as an educator and mentor. He inspired and guided countless young researchers, many of whom went on to make their own significant contributions to the fields of diabetes, endocrinology, and metabolism. His unwavering curiosity and dedication to understanding human diseases left an indelible mark on the scientific community.

Jesse Roth resided in Hurley, New York, at the time of his passing. His life was a testament to intellectual rigor, compassionate care, and a relentless pursuit of knowledge that has improved the lives of millions worldwide. He will be remembered as a visionary scientist and a compassionate leader whose work continues to resonate in the ongoing fight against metabolic diseases.